Shanghai No.1 Pharmacy Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,034	1,864	1,767	2,617	1,342	1,533
Other Revenue	51.35	51.35	52.23	38.5	56.25	53.79
Revenue	2,085	1,915	1,820	2,656	1,398	1,587
Revenue Growth (YoY)	12.56%	5.26%	-31.49%	89.94%	-11.89%	27.65%
Cost of Revenue	1,746	1,598	1,474	2,116	1,153	1,310
Gross Profit	339.03	317.2	345.21	540.36	244.86	276.82
Selling, General & Admin	334.91	318.56	315.85	307.58	230.69	227.8
Other Operating Expenses	5.7	5.88	8.36	9.53	4.71	4.96
Operating Expenses	319.72	305.27	333.8	333.73	235.93	233.83
Operating Income	19.3	11.93	11.41	206.63	8.94	42.99
Interest Expense	-5.03	-6.05	-7.59	-14.12	-3.15	-1.68
Interest & Investment Income	25.66	33.86	25.31	17.89	24.23	20.23
Currency Exchange Gain (Loss)	-0.18	-0.18	0.19	0.05	-	-
Other Non Operating Income (Expenses)	-29.32	3.42	-3.4	-3.94	0.26	-0.23
EBT Excluding Unusual Items	10.43	42.98	25.92	206.51	30.27	61.31
Gain (Loss) on Sale of Investments	0.38	0.38	12.14	0.29	-	-
Gain (Loss) on Sale of Assets	77.59	168.89	64.73	-0.07	1.23	0.07
Asset Writedown	-4.99	-4.99	-4.69	-19.99	-	-0.22
Other Unusual Items	9.02	9.02	19.41	3.79	33.75	29.49
Pretax Income	92.42	216.27	117.51	190.52	65.24	90.66
Income Tax Expense	22.14	52.66	28.24	46.96	15.82	22.11
Earnings From Continuing Operations	70.28	163.62	89.28	143.56	49.42	68.54
Minority Interest in Earnings	-1.27	-0.55	-	-	-	-
Net Income	69.01	163.06	89.28	143.56	49.42	68.54
Net Income to Common	69.01	163.06	89.28	143.56	49.42	68.54
Net Income Growth	-61.47%	82.65%	-37.81%	190.49%	-27.90%	29.10%
Shares Outstanding (Basic)	223	223	223	224	225	221
Shares Outstanding (Diluted)	223	223	223	224	225	221
Shares Change (YoY)	0.07%	0.08%	-0.50%	-0.14%	1.60%	-0.05%
EPS (Basic)	0.31	0.73	0.40	0.64	0.22	0.31
EPS (Diluted)	0.31	0.73	0.40	0.64	0.22	0.31
EPS Growth	-61.49%	82.50%	-37.50%	190.91%	-29.03%	29.17%
Free Cash Flow	104.03	-2.91	44.61	120.94	23.92	72.01
Free Cash Flow Per Share	0.47	-0.01	0.20	0.54	0.11	0.33
Dividend Per Share	0.220	0.220	0.125	0.195	0.070	0.095
Dividend Growth	76.00%	76.00%	-35.90%	178.57%	-26.32%	26.67%
Gross Margin	16.26%	16.56%	18.97%	20.34%	17.51%	17.44%
Operating Margin	0.93%	0.62%	0.63%	7.78%	0.64%	2.71%
Profit Margin	3.31%	8.51%	4.91%	5.41%	3.53%	4.32%
Free Cash Flow Margin	4.99%	-0.15%	2.45%	4.55%	1.71%	4.54%
EBITDA	25.07	18.38	18.79	214.25	16.71	51.35
EBITDA Margin	1.20%	0.96%	1.03%	8.07%	1.20%	3.24%
D&A For EBITDA	5.77	6.46	7.38	7.62	7.77	8.36
EBIT	19.3	11.93	11.41	206.63	8.94	42.99
EBIT Margin	0.93%	0.62%	0.63%	7.78%	0.64%	2.71%
Effective Tax Rate	23.96%	24.35%	24.03%	24.65%	24.25%	24.39%
Revenue as Reported	2,085	1,915	1,820	2,656	1,398	1,587
Advertising Expenses	-	6.11	6.6	4.75	2.99	4.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.